Lower GI 2016

Other Prognostic Factors

• ACT 1 trial :

low Hb associated with increased anal cancer death ( p=0.008 )

EORTC 22861 :

•

skin ulceration associated with loco-regional failure (p=0.003) and overall survival(p=0.005)